InvestorsHub Logo
Followers 0
Posts 295
Boards Moderated 0
Alias Born 08/28/2017

Re: None

Tuesday, 10/17/2017 12:30:55 PM

Tuesday, October 17, 2017 12:30:55 PM

Post# of 118360
"We are very excited at how well the medicinal chemistry program is working," says David Koos, Ph.D., Chairman & CEO Regen BioPharma Inc. "We will file additional composition of matter patents around these structures shortly and we should be able to focus on just one or two of the best ones moving forward."